DuChemBIO Co.,Ltd. (KOSDAQ:176750)

DuChemBIO Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	6,480	7,994	4,001
Depreciation & Amortization	6,870	5,565	5,760
Loss (Gain) From Sale of Assets	-2.85	0.18	-16.28
Asset Writedown & Restructuring Costs	72.81	-	30.7
Loss (Gain) From Sale of Investments	-207.24	-387.82	-92.13
Loss (Gain) on Equity Investments	24.69	-1,106	69.64
Stock-Based Compensation	58.65	31.97	236.54
Provision & Write-off of Bad Debts	-119.23	156.15	-165.84
Other Operating Activities	589.68	-2,039	929.66
Change in Accounts Receivable	-1,865	-1,834	-131.89
Change in Inventory	263.61	-74.64	-534.11
Change in Accounts Payable	-137.55	-597.38	411.37
Change in Other Net Operating Assets	-2,088	-679.24	-2,057
Operating Cash Flow	9,939	7,029	8,441
Operating Cash Flow Growth	41.40%	-16.73%	-
Capital Expenditures	-865.67	-1,589	-1,147
Sale of Property, Plant & Equipment	-	-	31
Sale (Purchase) of Intangibles	-12.16	-283.1	-150
Investment in Securities	-	11.06	-
Other Investing Activities	120	-204.41	-132.8
Investing Cash Flow	-757.82	-1,816	-1,299
Long-Term Debt Issued	1,000	-	-
Long-Term Debt Repaid	-5,422	-7,925	-7,766
Net Debt Issued (Repaid)	-4,422	-7,925	-7,766
Issuance of Common Stock	-	11,440	-
Other Financing Activities	-	-7.75	-
Financing Cash Flow	-4,422	3,507	-7,766
Foreign Exchange Rate Adjustments	-0.06	-	-0.19
Net Cash Flow	4,760	8,720	-624.54
Free Cash Flow	9,074	5,440	7,293
Free Cash Flow Growth	66.81%	-25.41%	-
Free Cash Flow Margin	23.52%	15.28%	21.02%
Free Cash Flow Per Share	319.36	202.48	272.63
Cash Interest Paid	800.08	1,087	919.41
Cash Income Tax Paid	259.56	144.92	90.38
Levered Free Cash Flow	8,061	4,629	-
Unlevered Free Cash Flow	8,724	5,311	-
Change in Working Capital	-3,827	-3,185	-2,312

Source: S&P Global Market Intelligence. Standard template. Financial Sources.